Metagenomi

📍 Emeryville, United States👥 234 employees💰 Last funded Apr 2022
Biotechnology Research🌐 metagenomi.co
Website LinkedIn
Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using our proprietary, comprehensive metagenomics-derived genome editing toolbox. We believe tools with capa­bil­i­ties that go beyond the cur­rent tech­nol­o­gy land­scape will be required in order to reach the full ther­a­peu­tic poten­tial of genome edit­ing. By har­ness­ing the pow­er of metage­nomics, the study of genomes recov­ered from uncul­ti­vat­ed organ­isms in the nat­ur­al envi­ron­ment, we are dis­cov­er­ing and devel­op­ing a suite of nov­el genome edit­ing tools with the poten­tial to make any desired ther­a­peu­tic gene edit, any­where in the human genome.
7
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
6
Switzerland
1
Investor activity2019–2022 · investors recorded per year
20193202022021120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Metagenomi?
Metagenomi has 7 investors on record on gritt.io.
When did Metagenomi last raise funding?
The most recent investment in Metagenomi recorded on gritt.io was in April 2022.
What industry is Metagenomi in?
Metagenomi operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Metagenomi based?
Metagenomi is headquartered in Emeryville, United States.